These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Anti-meningococcal vaccines: diversity of vaccination policies and recommendations]. Gendrel D Arch Pediatr; 2012 Sep; 19 Suppl 2():S70-6. PubMed ID: 22883370 [TBL] [Abstract][Full Text] [Related]
3. Vaccines for the poor: meningococcal A conjugate vaccine in Africa. Isaacs D J Paediatr Child Health; 2011 Jan; 47(1-2):66. PubMed ID: 21255149 [No Abstract] [Full Text] [Related]
4. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Larrauri A; Cano R; García M; Mateo Sd Vaccine; 2005 Jul; 23(32):4097-100. PubMed ID: 15908059 [TBL] [Abstract][Full Text] [Related]
5. Meningococcal vaccine for infants? Campos-Outcalt D J Fam Pract; 2012 Aug; 61(8):482-4. PubMed ID: 22871657 [TBL] [Abstract][Full Text] [Related]
13. Recent trends in meningococcal epidemiology and current vaccine recommendations. Baltimore RS Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164 [TBL] [Abstract][Full Text] [Related]
14. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026 [No Abstract] [Full Text] [Related]
15. Meningococcal vaccine for adolescents and college freshmen. FDA Consum; 2005; 39(5):4. PubMed ID: 16421984 [No Abstract] [Full Text] [Related]
16. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Welte R; van den Dobbelsteen G; Bos JM; de Melker H; van Alphen L; Spanjaard L; Rümke HC; Postma MJ Vaccine; 2004 Dec; 23(4):470-9. PubMed ID: 15530695 [TBL] [Abstract][Full Text] [Related]
17. Infectious disease. An ill wind, bringing meningitis. Roberts L Science; 2008 Jun; 320(5884):1710-5. PubMed ID: 18583588 [No Abstract] [Full Text] [Related]
18. Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines. Hargreaves JR; Greenwood B; Clift C; Goel A; Roemer-Mahler A; Smith R; Heymann DL Lancet; 2011 Nov; 378(9806):1885-93. PubMed ID: 21664678 [TBL] [Abstract][Full Text] [Related]
19. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine. Macneil JR; Cohn AC; Zell ER; Schmink S; Miller E; Clark T; Messonnier NE; Pediatr Infect Dis J; 2011 Jun; 30(6):451-5. PubMed ID: 21206392 [TBL] [Abstract][Full Text] [Related]
20. Is public meningococcal C vaccination the preferred value for money at cost-neutral? Gravatt L N Z Med J; 2013 Oct; 126(1384):123-5. PubMed ID: 24162638 [No Abstract] [Full Text] [Related] [Next] [New Search]